In the case of infection with Candida albicans, it is presumed that inflammation is stimulated through the secretion of IL-17, increased intestinal permeability, and molecular mimicry in certain species, leading to the onset of spondyloarthritis, inflammatory bowel disease (IBD), or psoriasis. Here, IL17A is linked to psoriasis.